Skip to main content

Table 3 Tumour uptake, blood levels and tumour-to-blood ratios for 131I- and 111In-CHX-A″ DTPA-labelled hu3S193 antibody variants in A431 tumour-bearing mice

From: Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers

Antibody

Time (hours)

Tumour (%ID/g)

Blood (%ID/g)

T/B

Tumour (%ID/g)

Blood (%ID/g)

T/B

  

131I

111In

Wild type

4

9.02 ± 0.73a

39.37 ± 3.33

1:4

13.17 ± 2.40

35.56 ± 5.48

1:3

 

24

17.37 ± 1.25

22.17 ± 1.81

1:1

33.42 ± 7.75

21.83 ± 3.32

2:1

 

48

17.58 ± 2.60

15.09 ± 1.70

1:1

39.01 ± 3.92

14.50 ± 1.11

3:1

 

72

17.76 ± 1.72

13.18 ± 1.91

1:1

39.27 ± 4.33

9.97 ± 1.85

4:1

 

120

15.10 ± 3.89

7.13 ± 1.46

2:1

37.26 ± 8.67

5.78 ± 2.12

6:1

 

168

11.40 ± 4.56

4.44 ± 1.56

2:1

24.24 ± 2.57

1.06 ± 0.32

9:1

I253A

4

10.01 ± 3.25

29.95 ± 3.59

1:3

9.64 ± 0.74

38.74 ± 3.57

1:4

 

24

9.95 ± 2.26

6.94 ± 1.34

1:1

27.17 ± 2.00

17.99 ± 1.57

2:1

 

48

5.07 ± 2.10

1.09 ± 0.32

5:1

31.75 ± 3.98

10.19 ± 1.04

3:1

 

72

2.03 ± 0.81

0.04 ± 0.08

48:1

33.11 ± 4.05

7.64 ± 1.32

4:1

 

120

0.78 ± 0.79

0.00 ± 0.00

>500:1

23.68 ± 6.52

2.99 ± 0.73

8:1

 

168

0.10 ± 0.14

0.00 ± 0.00

>500:1

14.66 ± 4.80

1.14 ± 0.63

13:1

H435A

4

8.79 ± 0.45

32.46 ± 2.63

1:4

10.25 ± 1.30

37.97 ± 2.68

1:4

 

24

11.52 ± 1.38

8.46 ± 1.89

1:1

33.69 ± 3.77

17.09 ± 1.59

2:1

 

48

5.53 ± 1.18

2.27 ± 1.21

2:1

31.10 ± 4.76

7.65 ± 1.60

4:1

 

72

3.18 ± 0.22

0.69 ± 0.17

5:1

28.48 ± 4.00

5.18 ± 1.40

6:1

 

120

1.64 ± 1.09

0.00 ± 0.00

>500:1

25.60 ± 4.16

3.19 ± 0.62

8:1

 

168

0.54 ± 0.58

0.00 ± 0.00

>500:1

15.34 ± 4.65

1.16 ± 0.62

13:1

H310A

4

9.80 ± 1.83

32.56 ± 3.00

1:3

10.79 ± 2.87

30.52 ± 5.06

1:3

 

24

9.58 ± 1.73

3.85 ± 0.35

3:1

22.85 ± 2.93

11.05 ± 1.62

2:1

 

48

5.10 ± 1.87

0.01 ± 0.02

>500:1

25.10 ± 2.91

5.61 ± 2.01

5:1

 

72

2.43 ± 1.10

0.00 ± 0.00

>500:1

22.12 ± 2.55

2.56 ± 0.60

9:1

 

120

1.81 ± 0.71

0.00 ± 0.00

>500:1

12.89 ± 1.33

0.54 ± 0.16

24:1

 

168

1.45 ± 0.99

0.00 ± 0.00

>500:1

8.64 ± 0.96

0.17 ± 0.06

51:1

I253A/H310A

4

9.90 ± 2.42

30.20 ± 3.97

1:3

8.92 ± 2.00

28.84 ± 6.05

1:3

 

24

8.04 ± 1.82

3.88 ± 1.32

2:1

23.72 ± 0.85

5.28 ± 0.81

5:1

 

48

5.10 ± 0.76

0.06 ± 0.09

80:1

14.84 ± 1.43

0.46 ± 0.07

32:1

 

72

3.04 ± 1.58

0.00 ± 0.00

>500:1

11.92 ± 2.46

0.08 ± 0.03

154:1

 

120

1.92 ± 0.53

0.00 ± 0.00

>500:1

5.85 ± 1.31

0.00 ± 0.00

>500:1

 

168

1.43 ± 0.27

0.00 ± 0.00

>500:1

3.52 ± 1.00

0.00 ± 0.00

>500:1

  1. aData presented as percentage injected dose per gramme tissue (mean ± SD, n = 5)